Navigation Links
Sigma-Aldrich Launches Senior Notes Offering
Date:10/25/2010

ST. LOUIS, Oct. 25 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) announced today that it intends to offer, subject to market and other conditions, approximately $250 million of its senior notes due 2020 in an underwritten public offering.  Sigma-Aldrich plans to use the net proceeds of the notes offering for general corporate purposes.

Banc of America Securities LLC and J.P. Morgan Securities Inc. will act as joint book-running managers for the offering.

This news release does not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the notes in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such states.

When available, copies of the prospectus and prospectus supplement, subject to completion, relating to the notes may be obtained by contacting Banc of America Securities LLC, 100 West 33rd Street, New York, NY  10001, Attention: Prospectus Department, or by telephone at 1-800-294-1322 or email at dg.prospectus_distribution@baml.com, or J.P. Morgan Securities LLC, 383 Madison Avenue, New York, NY  10179. Before you invest, you should read the prospectus and the prospectus supplement, the registration statement and other documents that Sigma-Aldrich has filed with the Securities and Exchange Commission for more complete information about Sigma-Aldrich and this offering.  Investors may also obtain these documents for free by visiting the EDGAR system on the SEC's website at www.sec.gov or from the underwriters with your request.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and as key components in pharmaceutical, diagnostic and other high technology manufacturing.  We have customers in life science companies, university and government institutions, hospitals and in industry.  Over one million scientists and technologists use our products.  Sigma-Aldrich operates in 40 countries and has 7,700 employees providing excellent service worldwide.  We are committed to accelerating our Customers' success through leadership in Life Science, High Technology and Service.


'/>"/>
SOURCE Sigma-Aldrich Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sigma-Aldrich to Present at the Stifel Nicolaus 2010 Healthcare Conference on Thursday, September 16, 2010.
2. Sigma-Aldrich® Receives National Institutes of Health Funding for Cardiovascular Disease Research
3. Sigma-Aldrich to Present at the Deutsche Bank 35th Annual Health Care Conference Wedesday, May 5, 2010.
4. Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc.
5. Sigma-Aldrich(R) Licenses RAFT Polymerization Technology From CSIRO(R)
6. Sigma-Aldrich Becomes the Sole U.S. and Canada Distributor of Kromasil(R) HPLC Columns Through Agreement With Eka Chemicals
7. Sigma-Aldrich to Present at the 28th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2010
8. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
9. Sigma-Aldrich Announces SAGE(TM) Priority Partners Program; Seeks Researchers to Evaluate New Knockout Rat Models
10. Sigma-Aldrich(R) Partners With Flow Chemistry Leader ThalesNano to Provide CatCart(R) Catalyst Products for Rapidly Growing Market
11. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
(Date:4/18/2017)... 2017  Cardinal Health (NYSE: CAH ) ... earnings per share (EPS) guidance and providing a preliminary ... conjunction with this morning,s announcement of the planned acquisition ... Insufficiency businesses. Cardinal Health now believes that ... at the bottom of its previous guidance range of ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often ... it difficult for lab operators and management to assess these processes with a ... wasteful or unnecessary actions. , Created with the help of both internal ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, and Omega ... Omega Station” is the creation of published author, Chris Jackson. Chris Jackson grew ... works in the Dallas Independent School District teaching English. He is heavily involved in ...
(Date:4/24/2017)... ... ... A 2-in-1 bottleless water appliance provides both purified drinking ... here are the ways in which this technology can benefit dental offices: , ... oxygenated water, with both cold and hot options. , Convenience for Dentists and ...
(Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... shows that U.S. consumers can save an average of 70% when buying medication ... (up to 97%) are available when purchasing from other countries. The report (chart ...
(Date:4/21/2017)... West Palm Beach, FL (PRWEB) , ... April 21, 2017 , ... The staff at ... FACS , will be taking part in the 2017 London Marathon. Set to take place ... variety of charitable organizations. This year, Dr. Schwartz will run as part of team EMPOWER, ...
Breaking Medicine News(10 mins):